510(k) K200533
K200533 is an FDA 510(k) premarket notification submitted by Binx Health, Inc. for the device "binx io CT/NG Assay and binx io CT/NG System". The FDA issued a decision of Substantially Equivalent on Apr 27, 2020. The device falls under product code QEP (Nucleic Acid Detection System For Non-Viral Microorganism(S) Causing Sexually Transmitted Infections), a Class II device regulated under 21 CFR 866.3393. Binx Health, Inc. has 1 other 510(k) clearance on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Apr 27, 2020
- Date Received
- Mar 2, 2020
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Nucleic Acid Detection System For Non-Viral Microorganism(S) Causing Sexually Transmitted Infections
- Device Class
- Class II
- Regulation Number
- 866.3393
- Review Panel
- MI
- Submission Type
- 510(k)
A device to detect nucleic acids from non-viral microorganism(s) causing sexually transmitted infections is an in vitro diagnostic device intended for the detection and identification of nucleic acids from non-viral microorganism(s) in clinical specimens collected from patients suspected of sexually transmitted infections. The device is intended to aid in the diagnosis of non-viral sexually transmitted infections in conjunction with other clinical and laboratory data.
Need the full FDA record for Binx Health, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.